Toggle navigation
Home
Medical
Remdesivir Takes Top Spot for US Hospital Spending: Report
2-2-2022
Medical
https://www.medscape.com/cx/rssfeeds/2700.xml
85
The COVID-19 drug remdesivir last year overtook AbbVie's 20-year-old arthritis drug Humira as the medicine that US hospitals spent the most on. Reuters Health Information
Share
Tweet
+1
Read The Rest
at : https://www.medscape.com/cx/rssfeeds/2700.xml
Related News
Severe COVID: Tracheostomy Linked to Lower In-Hospital...
Climate Change Jeopardizes Healthcare Services, Report Says
Fruit Leathers Have Detectable Pesticides: Report
Pediatric patients undergoing surgical stent removal...
Researchers report the effects of a common Japanese...
Report: Women, men experience different heart disease...
How to spot mouth cancer
Oral health charity responds to National Food Strategy...
The use of augmented reality navigation technology in...
APA Report, Virtual Model Highlight US Psychiatric Bed...